Related Experiment Video
Updated: Jul 18, 2026
05:49
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
The environment and antiphospholipid syndrome.
1Department of Medicine 'E', Meir Medical Center, Sheba Medical Center, Israel.
Lupus
|December 13, 2006
Summary
Autoimmune diseases arise from complex genetic and environmental interactions. Antiphospholipid syndrome (APS) is a newly recognized autoimmune condition characterized by thrombosis and pregnancy issues linked to specific antibodies.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Autoimmune disease etiology is multifactorial, involving complex genetic and environmental interactions.
- The precise contribution of genetic versus environmental factors to autoimmune disease susceptibility remains unclear.
- Diverse clinical presentations of autoimmune diseases likely result from unique combinations of these factors.
Purpose of the Study:
- To introduce antiphospholipid syndrome (APS) as a newly diagnosed autoimmune disease.
- To describe the key clinical and serological characteristics of APS.
Main Methods:
- This abstract does not detail specific methods.
- The text describes the defining features of APS.
Main Results:
- Antiphospholipid syndrome (APS) is characterized by vascular thrombosis and/or pregnancy morbidity.
- Diagnostic criteria involve specific autoantibodies: anticardiolipin (aCL), anti-beta2-glycoprotein-I (anti-beta2GPI), and lupus anticoagulant (LAC).
Conclusions:
- Antiphospholipid syndrome (APS) represents a distinct clinical entity within autoimmune diseases.
- Understanding the interplay of genetic and environmental factors is crucial for defining autoimmune disease susceptibility and presentation.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...